J R Farndon
Bristol Royal Infirmary(GB)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Estrogen and related hormone effects, Health and Medical Research Impacts, Diversity and Career in Medicine
Most-Cited Works
- → EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER(1987)878 cited
- → Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer(1992)380 cited
- → Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status(2006)267 cited
- → Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.(1985)227 cited
- → EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER(1989)218 cited
- → Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup(1991)166 cited
- Epidermal growth factor receptor and other oncogenes as prognostic markers.(1992)
- → The diagnosis and management of mixed arterial/venous leg ulcers in community-based clinics(1998)84 cited
- The challenge of evaluating surgical procedures.(1992)
- → Influence of a specialised leg ulcer service and venous surgery on the outcome of venous leg ulcers(1998)65 cited